Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
To evaluates the effectiveness and safety of Toripalimab combined with Anlotinib and
chemotherapy for the first-line treatment of ES-SCLC, and maintenance therapy are Toripalimab
combined with Anlotinib.